
	Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics&#39; shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.
